Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v5-EN
Language French English
Date Updated 2018-07-27 2018-06-08
Drug Identification Number 02256193 02256193
Brand name CESAMET CESAMET
Common or Proper name CESAMET CESAMET
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients NABILONE NABILONE
Strength(s) 0.5MG 0.5MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size na na
ATC code A04AD A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-01-19 2018-01-19
Estimated end date 2018-07-25
Actual end date 2018-07-25
Shortage status Resolved Actual shortage
Company comments
Health Canada comments